Abstract 8341: High-Sensitivity C-Reactive Protein, All-Cause Mortality and Heart Failure Hospitalization After Acute Coronary Syndrome in Type 2 Diabetes: Insights from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) Trial
Background: Patients with type 2 diabetes (T2D) remain at high risk for adverse outcomes after acute coronary syndrome (ACS). High-sensitivity C-reactive protein (hsCRP) may identify residual risk in this setting. Objective: To evaluate whether baseline hsCRP is associated with all-cause mortality (ACM) and he...